Basilea Pharmaceutica’s CHF 75 Million Senior Secured Loan Agreement with Athyrium

BianchiSchwald advised Athyrium on the deal.The listed company Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company entered into a senior secured loan agreement with funds…

This content is for members only.
Login to Read More Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for members only.
Login to Read More Join Now